Risk factors for recurrent urinary tract infections among women in a large integrated health care organization in the United States

Urinary tract infections (UTIs) occur commonly and often recur. However, recent data on the epidemiology of recurrent UTI (rUTI) are scarce. Between 01/01/2016-31/12/2020, index uncomplicated UTIs (uUTI) from office, emergency department (ED), hospital, and virtual care settings were identified from...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 230; no. 5; pp. e1101 - e1111
Main Authors: Ackerson, Bradley K, Tartof, Sara Y, Chen, Lie H, Contreras, Richard, Reyes, Iris Anne C, Ku, Jennifer H, Pellegrini, Michele, Schmidt, Johannes E, Bruxvoort, Katia J
Format: Journal Article
Language:English
Published: United States Oxford University Press 15-11-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Urinary tract infections (UTIs) occur commonly and often recur. However, recent data on the epidemiology of recurrent UTI (rUTI) are scarce. Between 01/01/2016-31/12/2020, index uncomplicated UTIs (uUTI) from office, emergency department (ED), hospital, and virtual care settings were identified from electronic health records of women at Kaiser Permanente Southern California. We defined rUTI as ≥3 UTI within 365 days or ≥2 UTI within 180 days. We determined the proportion of women with cystitis index uUTI who had rUTI and examined factors associated with rUTIs using modified multivariable Poisson regression. Among 374,171 women with cystitis index uUTI, 54,318 (14.5%) had rUTI. A higher proportion of women with rUTI compared to those without rUTI were age 18-27 or ≥78 years at index uUTI (19.7% vs 18.7% and 9.0% vs 6.0%, respectively), were immunocompromised, or had a positive urine culture at index uUTI. In multivariable analyses, characteristics associated with rUTI included younger or older age (48-57 vs 18-27 years aRR=0.83 [95% CI: 0.80-0.85]; ≥78 vs 18-27 years aRR=1.07 [95%CI=1.03-1.11]), Charlson Comorbidity Index (≥3 vs 0, aRR=1.12 [95%CI:1.08-1.17]), and diabetes mellitus (aRR=1.07 [95%CI:1.04-1.10]). More frequent prior year outpatient and ED encounters, oral antibiotic prescriptions, oral contraceptive prescriptions, positive culture at index uUTI, and antibiotic resistant organisms were also associated with increased risk of rUTI. The high risk of rUTI among women with cystitis is concerning, especially given previous reports of increasing UTI incidence. Current assessment of the epidemiology of rUTI may guide the development of preventive interventions against UTI.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Potential conflicts of interest. B. K. A., S. Y. T., L. H. C., R. C., I. A. C. R., and J. H. K. are employees of KPSC, which has been contracted by GlaxoSmithKline (GSK) to conduct this study. K. J. B. is an adjunct investigator at KPSC. B. K. A. received funding from Dynavax, Genentech, Moderna, GSK, and Pfizer unrelated to this work. S. Y. T. received funding from Pfizer unrelated to this work. J. H. K. received funding from Moderna unrelated to this work. K. J. B. received funding from Dynavax, Moderna, and Pfizer unrelated to this work. M. P. is a full-time employee of the GSK group of companies and holds shares of the GSK group of companies. J. E. S. is a full-time employee of the GSK group of companies and holds shares of the GSK group of companies.
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
ISSN:0022-1899
1537-6613
1537-6613
DOI:10.1093/infdis/jiae331